Iromedica AG in Tissue and Hygiene (Switzerland)

July 2014 | 2 pages | ID: I0E843C4724EN
Euromonitor International Ltd

Abstracts

Iromedica AG will continue to employ research and development to strengthen the competitive position of its Cami-moll brand in Switzerland. According to company information, a particular focus will be given to the maintenance of a high-quality products, as well as the release of premium, value-added features. Iromedica will direct its marketing efforts towards strengthening Cami-moll’s image as a trusted, domestic brand in Switzerland, thereby tapping into Swiss consumers’ growing preference...

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Away-From-Home Tissue and Hygiene, Retail Tissue and Hygiene, Total Tissue and Hygiene.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Tissue and Hygiene market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Iromedica AG: Key Facts
Company Background
Production
Summary 2 Iromedica AG: Production Statistics 2013
Competitive Positioning
Summary 3 Iromedica AG: Competitive Position 2013